Skip to content

Ftivazide

ANTIINFECTIVES FOR SYSTEMIC USE

Also known as: anhydrous ftivazide, ftivazid, N-Isonicotinamido-3-methoxy-4-hydroxybenzalimine, phthivazid, phthivazide, vanillaberon, vanizide

ATC J04AC02

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Ftivazide is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including MPO. Recorded indications include Tuberculosis.

  • Molecular targets: MPO (1 listed in DrugCentral).
  • Indications: Tuberculosis.
  • ATC code: J04AC02 (Hydrazides).
  • Molecular formula: C14H13N3O3; molecular weight 271.28 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Tuberculosis

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
MyeloperoxidaseMPOunknownIC50 6.34

ATC classification

ATC codeTherapeutic hierarchy
J04AC02ANTIINFECTIVES FOR SYSTEMIC USE › ANTIMYCOBACTERIALS › DRUGS FOR TREATMENT OF TUBERCULOSIS › Hydrazides

Chemical structure

Molecular formulaC14H13N3O3
Molecular weight271.28 g/mol
CAS number149-17-7
InChIKeyPSWOBQSIXLVPDV-UHFFFAOYSA-N
PubChem CID135412163
COC1=C(O)C=CC(C=NNC(=O)C2=CC=NC=C2)=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Ftivazide used for?

DrugCentral lists the following indications for Ftivazide: Tuberculosis.

How does Ftivazide work?

Its molecular targets in DrugCentral include MPO.

What is the chemical formula of Ftivazide?

Ftivazide has the molecular formula C14H13N3O3 and a molecular weight of 271.28 g/mol.

Browse: all drugs starting with F · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets1
Indications1
FormulaC14H13N3O3
DrugCentral ID1253
Interactive profile